The interleukin-10-1082A>G polymorphism and lymphoma risk: A meta-analysis

Cancer Biomarkers

Volumn 14, Issue 5, 2014, Pages 381-388

  Yu, Xinnian ^a   Chen, Baoan ^a   Cheng, Jian ^a   Gao, Chong ^a   Zhang, Xiaoping ^a   Bao, Wen ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

interleukin 10; Lymphoma; meta analysis; polymorphism; susceptibility

Indexed keywords

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; EMBASE; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HODGKIN DISEASE; HUMAN; INTERLEUKIN 10 GENE; LYMPHOMA; MEDLINE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TUMOR GENE; ALLELE; CASE CONTROL STUDY; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK; RISK FACTOR;

IL10 PROTEIN, HUMAN; INTERLEUKIN 10;

ALLELES; CASE-CONTROL STUDIES; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; LYMPHOMA; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84938679477     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-140406     Document Type: Article

References (25)

1. C. Bosetti, F. Levi, J. Ferlay, F. Lucchini, E. Negri and C. La Vecchia, Incidence and mortality from non-Hodgkin lymphoma in Europe: The end of an epidemic? Int J Cancer 123 (2008), 1917-23.
2. E. Lech-Maranda, L. Baseggio, J. Bienvenu, C. Charlot, F. Berger, D. Rigal, K. Warzocha, B. Coiffier and G. Salles, Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma, Blood 103 (2004), 3529-34.
3. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott and I.V. Hutchinson, An investigation of polymorphism in the interleukin-10 gene promoter, Eur J Immuno-genet 24 (1997), 1-8.
4. N. Rothman, C.F. Skibola, S.S. Wang, G. Morgan, Q. Lan, M.T. Smith, J.J. Spinelli, E. Willett, S. De Sanjose, P. Cocco, S.I. Berndt, P. Brennan, A. Brooks-Wilson, S. Wacholder, N. Becker, P. Hartge, T. Zheng, E. Roman, E.A. Holly, P. Boffetta, B. Armstrong, W. Cozen, M. Linet, F.X. Bosch, M.G. Ennas, T.R. Holford, R.P. Gallagher, S. Rollinson, P.M. Bracci, J.R. Cerhan, D. Whitby, P.S. Moore, B. Leaderer, A. Lai, C. Spink, S. Davis, R. Bosch, A. Scarpa, Y. Zhang, R.K. Severson, M. Yeager, S. Chanock and A. Nieters, Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium, Lancet Oncol 7 (2006), 27-38.
5. E. Lech-Maranda, W. Mlynarski, O. Grzybowska-Izydor-czyk, M. Borowiec, A. Pastorczak, B. Cebula-Obrzut, G. Klimkiewicz-Wojciechowska, M. Wcislo, M. Majewski, A. Kotkowska, T. Robak and K. Warzocha, Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia, Genes Chromosomes Cancer 52 (2013), 287-96.
6. Y. Zhang, M.Y. Wang, J. He, J.C. Wang, Y.J. Yang, L. Jin, Z.Y. Chen, X.J. Ma, M.H. Sun, K.Q. Xia, X.N. Hong, Q.Y. Wei and X.Y. Zhou, Tumor necrosis factor-alpha induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: A case-control study, PLoS One 7 (2012), e37846.
7. H.L. Ramkumar, F. Shen de, J. Tuo, R.M. Braziel, S.E. Coupland, J.R. Smith and C.C. Chan, IL-10-1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas, Graefes Arch Clin Exp Ophthalmol 250 (2012), 1541-8.
8. M.P. Purdue, Q. Lan, A. Kricker, A.E. Grulich, C.M. Vajdic, J. Turner, D. Whitby, S. Chanock, N. Rothman and B.K. Armstrong, Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study, Carcinogenesis 28 (2007), 704-12.
9. M. Persico, M. Capasso, E. Persico, M. Masarone, A. Renzo, D. Spano, S. Bruno and A. Iolascon, Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection, J Hepatol 45 (2006), 779-85.
10. A. Nieters, L. Beckmann, E. Deeg and N. Becker, Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk, Genes Immun 7 (2006), 615-24.
11. L.R. Munro, P.W. Johnston, N.A. Marshall, S.J. Canning, S.G. Hewitt, K. Tveita and M.A. Vickers, Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma, Leuk Lymphoma 44 (2003), 2083-8.
12. Q. Lan, T. Zheng, N. Rothman, Y. Zhang, S.S. Wang, M. Shen, S.I. Berndt, S.H. Zahm, T.R. Holford, B. Leaderer, M. Yeager, R. Welch, P. Boyle, B. Zhang, K. Zou, Y. Zhu and S. Chanock, Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma, Blood 107 (2006), 4101-8.
13. L.M. Cunningham, C. Chapman, R. Dunstan, M.C. Bell and D.J. Joske, Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma, Leuk Lymphoma 44 (2003), 251-5.
14. M. Berglund, U. Thunberg, G. Roos, R. Rosenquist and G. Enblad, The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma, Blood 105 (2005), 4894-5; author reply 4895.
15. E. Andrie, A. Michos, V. Kalampoki, A. Pourtsidis, M. Moschovi, S. Polychronopoulou, F. Athanasiadou-Piper-opoulou, M. Kalmanti, A. Hatzakis, D. Paraskevis, A. Nieters and E.T. Petridou, Genetic variants in immunoregulatory genes and risk for childhood lymphomas, Eur J Haematol 83 (2009), 334-42.
16. G. Wells, B. Shea, D. O'Connell, J. Robertson, J. Peterson, V. Welch, M. Losos and P. Tugwell, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca/programs/clinical-epide miology/oxford-web.ppt, (2010).
17. J.P. Higgins, S.G. Thompson, J.J. Deeks and D.G. Altman, Measuring inconsistency in meta-analyses, BMJ 327 (2003), 557-60.
18. N. Mantel and W. Haenszel, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst 22 (1959), 719-48.
19. R. DerSimonian and N. Laird, Meta-analysis in clinical trials, Control Clin Trials 7 (1986), 177-88.
20. C.B. Begg and M. Mazumdar, Operating characteristics of a rank correlation test for publication bias, Biometrics 50 (1994), 1088-101.
21. M. Egger, G. Davey Smith, M. Schneider and C. Minder, Bias in meta-analysis detected by a simple, graphical test, BMJ 315 (1997), 629-34.
22. N. Burdin, C. Peronne, J. Banchereau and F. Rousset, Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10, J Exp Med 177 (1993), 295-304.
23. J.Y. Blay, N. Burdin, F. Rousset, G. Lenoir, P. Biron, T. Philip, J. Banchereau and M.C. Favrot, Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor, Blood 82 (1993), 2169-74.
24. A. Tagore, W.M. Gonsalkorale, V. Pravica, A.H. Hajeer, R. McMahon, P.J. Whorwell, P.J. Sinnott and I.V. Hutchinson, Interleukin-10 (IL-10) genotypes in inflammatory bowel disease, Tissue Antigens 54 (1999), 386-90.
25. J. Wang, Q. Ding, Y. Shi, Q. Cao, C. Qin, J. Zhu, J. Chen and C. Yin, The interleukin-10-1082 promoter polymorphism and cancer risk: A meta-analysis, Mutagenesis 27 (2012), 305-12.